 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Analyst Coverage
| Analyst | Firm |
|---|---|
| Greg Fraser, MD | Banc of America Securities – Merrill Lynch |
| Adam Cutler | Canaccord Adams |
| Eric Schmidt, PhD | Cowen and Company |
| David Steinberg | Deutsche Bank |
| Irina Rivkind | Duncan-Williams, Inc. |
| Charles Duncan, PhD | JMP Securities |
| Juan Sanchez, MD | Ladenburg Thalmann |
| John Newman, PhD | Oppenheimer & Co., Inc. |
| Patricia L. Bank | Wedbush Morgan Securities |
Cadence Pharmaceuticals, Inc. is followed by the analyst(s) listed above. This list may not be all-inclusive. Please note that any opinions, estimates or forecasts regarding Cadence Pharmaceuticals, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cadence Pharmaceuticals, Inc. or its management. Cadence Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
| Stock Quote |
|---|
| CADX - (NASDAQ)
$7.28 - 0.03 Jul 29, 2010 4:00 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.